Search Results for "Warfarin In Vte"

15:20 EST 4th March 2015 | BioPortfolio

Matching Channels

Vitamin K

Vitamin K is a group of 2-methilo-naphthoquinone derivatives. There are three notable forms of vitamin K; K1 which can be synthesized by plants, K2 which can be formed by natural bacteria in the int...

Matching News

Reasons for Warfarin Discontinuation in ORBIT-AF

Delve into the real reasons for stopping warfarin in patients with atrial fibrillation. American Heart Journal

Warfarin in AF Patients on Dialysis: Worst of Both Worlds

Samuel Goldhaber describes the shocking findings of a study of warfarin use for AF prevention in patients on hemodialysis. theheart.org on Medscape

Warfarin Time in the Therapeutic Range: Room for Improvement

Dr Samuel Goldhaber reviews a study of nationwide management of warfarin for stroke prevention in atrial fibrillation, showing poor real-world TTRs. theheart.org on Medscape

Why the Sudden-Onset Bruising in a Warfarin Patient?

What is the reason behind the new-onset bruising in this older man who was previously stable on warfarin? Medscape Internal Medicine

Increased Stroke Risk Caused by Warfarin?

An increase in stroke risk supports the theory of a transient hypercoagulable state at the start of warfarin treatment in patients with atrial fibrillation. Medscape Neurology

INR variability predicts warfarin adverse effects

(HealthDay)—Unstable anticoagulation predicts warfarin adverse effects regardless of time in therapeutic range, according to a study published online Sept. 2 in Circulation: Cardiovascular Quality a...

Bleeding Risk Highest in Kidney Disease When Warfarin Starts

Patients with chronic kidney disease experience the greatest risk for major bleeding in the first 30 days after starting warfarin. Medscape Medical News

Taro Pharma Said To Order Warfarin Recall Over Quality Issues

Taro Pharmaceutical Industries, the U.S. arm of Sun Pharmaceutical Industries, reportedly has ordered a recall of its Warfarin Sodium anti-clotting drug in the wake of U.S. FDA findings of quality fai...

Matching PubMed Articles

Antithrombin Levels Are Unaffected by Warfarin Use.

Context.-The results of studies among patients with antithrombin deficiency have suggested that the use of warfarin will increase the level of antithrombin. Objective.-To reevaluate the effect of warf...

Reinforcement of Warfarin Action in a Patient Administered S-1.

A case showing reinforcement of the action of warfarin and potassium in a patient administered S-1 is reported.The patient was a 71-year-old man with left upper gingival cancer.He had ventricular tach...

VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance.

Warfarin is the most commonly prescribed anticoagulant drug; however, a narrow therapeutic range and a high risk of bleeding or stroke complicate its clinical use. Warfarin resistance was defined as p...

Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.

Patients with non-valvular atrial fibrillation (NVAF) are at risk for stroke and systemic embolism (SSE), and this risk can be decreased with adjusted-dose warfarin. Warfarin, however, is cumbersome t...

Anticoagulation clinic versus a traditional warfarin management model.

Warfarin is the most commonly prescribed oral anticoagulant. The management of warfarin is challenging, and current guidelines fail to include a model to assist practitioners in optimizing therapeutic...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement